BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goto T, Fujiya M, Konishi H, Sasajima J, Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, Sakatani A, Tanaka K, Nomura Y, Ueno N, Kashima S, Moriichi K, Mizukami Y, Kohgo Y, Okumura T. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer 2018;18:116. [PMID: 29385987 DOI: 10.1186/s12885-018-4006-5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Cappello F, Fais S. Extracellular vesicles in cancer pros and cons: the importance of the evidence-based medicine. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.01.011] [Reference Citation Analysis]
2 Chhoda A, Lu L, Clerkin BM, Risch H, Farrell JJ. Current approaches to pancreatic cancer screening. Am J Pathol. 2019;189:22-35. [PMID: 30558719 DOI: 10.1016/j.ajpath.2018.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
3 Nesteruk K, Levink IJ, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ. Extracellular vesicles derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.04.010] [Reference Citation Analysis]
4 Li X, Jiang W, Gan Y, Zhou W. The Application of Exosomal MicroRNAs in the Treatment of Pancreatic Cancer and Its Research Progress. Pancreas 2021;50:12-6. [PMID: 33370018 DOI: 10.1097/MPA.0000000000001713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fathi M, Ghafouri-Fard S, Abak A, Taheri M. Emerging roles of miRNAs in the development of pancreatic cancer. Biomed Pharmacother 2021;141:111914. [PMID: 34328099 DOI: 10.1016/j.biopha.2021.111914] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guo D, Yuan J, Xie A, Lin Z, Li X, Chen J. Diagnostic performance of circulating exosomes in human cancer: A meta-analysis. J Clin Lab Anal 2020;34:e23341. [PMID: 32309888 DOI: 10.1002/jcla.23341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Khawar MB, Abbasi MH, Siddique Z, Arif A, Sheikh N. An Update on Novel Therapeutic Warfronts of Extracellular Vesicles (EVs) in Cancer Treatment: Where We Are Standing Right Now and Where to Go in the Future. Oxid Med Cell Longev 2019;2019:9702562. [PMID: 31428232 DOI: 10.1155/2019/9702562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
8 Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, Lin LH, Lin YH, Liu JK, Liu YC, Lunde R, Shen WT. Exosome Processing and Characterization Approaches for Research and Technology Development. Adv Sci (Weinh) 2022;:e2103222. [PMID: 35332686 DOI: 10.1002/advs.202103222] [Reference Citation Analysis]
9 Chang CH, Pauklin S. Extracellular vesicles in pancreatic cancer progression and therapies. Cell Death Dis 2021;12:973. [PMID: 34671031 DOI: 10.1038/s41419-021-04258-7] [Reference Citation Analysis]
10 Yang Z, LaRiviere MJ, Ko J, Till JE, Christensen T, Yee SS, Black TA, Tien K, Lin A, Shen H, Bhagwat N, Herman D, Adallah A, O'Hara MH, Vollmer CM, Katona BW, Stanger BZ, Issadore D, Carpenter EL. A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 2020;26:3248-58. [PMID: 32299821 DOI: 10.1158/1078-0432.CCR-19-3313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
11 Hosseini K, Ranjbar M, Pirpour Tazehkand A, Asgharian P, Montazersaheb S, Tarhriz V, Ghasemnejad T. Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing. J Transl Med 2022;20:30. [PMID: 35033106 DOI: 10.1186/s12967-022-03231-y] [Reference Citation Analysis]
12 Ma C, Jiang F, Ma Y, Wang J, Li H, Zhang J. Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic. Dose Response 2019;17:1559325819891004. [PMID: 31839757 DOI: 10.1177/1559325819891004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
13 Li Y, Zhao W, Wang Y, Wang H, Liu S. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment. J Nanobiotechnology 2022;20:208. [PMID: 35501802 DOI: 10.1186/s12951-022-01382-0] [Reference Citation Analysis]
14 Chen K, Wang Q, Kornmann M, Tian X, Yang Y. The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review. Front Oncol 2021;11:644358. [PMID: 33718244 DOI: 10.3389/fonc.2021.644358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Clin Transl Med 2021;11:e520. [PMID: 34586739 DOI: 10.1002/ctm2.520] [Reference Citation Analysis]
16 Takeda Y, Kobayashi S, Kitakaze M, Yamada D, Akita H, Asai A, Konno M, Arai T, Kitagawa T, Ofusa K, Yabumoto M, Hirotsu T, Vecchione A, Taniguchi M, Doki Y, Eguchi H, Ishii H. Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes. Cells 2020;9:E1645. [PMID: 32659892 DOI: 10.3390/cells9071645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bunduc S, Gede N, Váncsa S, Lillik V, Kiss S, Juhász MF, Erőss B, Szakács Z, Gheorghe C, Mikó A, Hegyi P. Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma –a systematic review and meta-analysis. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.01.001] [Reference Citation Analysis]
18 Cheng H, Yang Q, Wang R, Luo R, Zhu S, Li M, Li W, Chen C, Zou Y, Huang Z, Xie T, Wang S, Zhang H, Tian Q. Emerging Advances of Detection Strategies for Tumor-Derived Exosomes. Int J Mol Sci 2022;23:868. [PMID: 35055057 DOI: 10.3390/ijms23020868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kok VC, Yu CC. Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development. Int J Nanomedicine 2020;15:8019-36. [PMID: 33116515 DOI: 10.2147/IJN.S272378] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
20 Strømme O, Heck KA, Brede G, Lindholm HT, Otterlei M, Arum CJ. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors. Curr Issues Mol Biol 2021;43:286-300. [PMID: 34199766 DOI: 10.3390/cimb43010024] [Reference Citation Analysis]
21 Chen J, Yao D, Chen W, Li Z, Guo Y, Zhu F, Hu X. Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer. Int J Biol Markers 2022;:17246008211070018. [PMID: 35001683 DOI: 10.1177/17246008211070018] [Reference Citation Analysis]
22 Wu L, Zhou WB, Zhou J, Wei Y, Wang HM, Liu XD, Chen XC, Wang W, Ye L, Yao LC, Chen QH, Tang ZG. Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer. Oncol Lett 2020;20:1432-40. [PMID: 32724386 DOI: 10.3892/ol.2020.11691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Buscail E, Maulat C, Muscari F, Chiche L, Cordelier P, Dabernat S, Alix-Panabières C, Buscail L. Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2019;11:E852. [PMID: 31248203 DOI: 10.3390/cancers11060852] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
24 Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871:455-468. [PMID: 31047959 DOI: 10.1016/j.bbcan.2019.04.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 26.0] [Reference Citation Analysis]
25 Wong CH, Chen YC. Clinical significance of exosomes as potential biomarkers in cancer. World J Clin Cases 2019; 7(2): 171-190 [PMID: 30705894 DOI: 10.12998/wjcc.v7.i2.171] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
26 Moutinho-Ribeiro P, Macedo G, Melo SA. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Front Endocrinol (Lausanne) 2018;9:779. [PMID: 30671023 DOI: 10.3389/fendo.2018.00779] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
27 Zhang W, Xing J, Liu T, Zhang J, Dai Z, Zhang H, Wang D, Tang D. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. Cell Commun Signal 2022;20:1. [PMID: 34980146 DOI: 10.1186/s12964-021-00806-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li W, Zhang S, Wang D, Zhang H, Shi Q, Zhang Y, Wang M, Ding Z, Xu S, Gao B, Yan M. Exosomes Immunity Strategy: A Novel Approach for Ameliorating Intervertebral Disc Degeneration. Front Cell Dev Biol 2022;9:822149. [DOI: 10.3389/fcell.2021.822149] [Reference Citation Analysis]
29 Aalami AH, Abdeahad H, Mesgari M. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis. Biomarkers 2021;26:103-13. [PMID: 33434077 DOI: 10.1080/1354750X.2021.1875504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
30 Tang S, Yu S, Cheng J, Zhang Y, Huang X. The versatile roles and clinical implications of exosomal mRNAs and microRNAs in cancer. Int J Biol Markers 2020;35:3-19. [PMID: 32389046 DOI: 10.1177/1724600820920293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Doyle LM, Wang MZ. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells. 2019;8. [PMID: 31311206 DOI: 10.3390/cells8070727] [Cited by in Crossref: 353] [Cited by in F6Publishing: 363] [Article Influence: 117.7] [Reference Citation Analysis]
32 Xue J, Jia E, Ren N, Lindsay A, Yu H. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review. Onco Targets Ther 2019;12:6665-84. [PMID: 31692495 DOI: 10.2147/OTT.S207963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhao Z, Fan J, Hsu YS, Lyon CJ, Ning B, Hu TY. Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application. Lab Chip 2019;19:1114-40. [PMID: 30882822 DOI: 10.1039/c8lc01123k] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
34 Logozzi M, Mizzoni D, Di Raimo R, Fais S. Exosomes: A Source for New and Old Biomarkers in Cancer. Cancers (Basel) 2020;12:E2566. [PMID: 32916840 DOI: 10.3390/cancers12092566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
35 Bhat EA, Sajjad N, Thokar FM. Current advancement of exosomes as biomarkers for cancer diagnosis and forecasting. Cancer Treat Res Commun 2021;28:100417. [PMID: 34126578 DOI: 10.1016/j.ctarc.2021.100417] [Reference Citation Analysis]
36 Mocan LP, Ilieș M, Melincovici CS, Spârchez M, Crăciun R, Nenu I, Horhat A, Tefas C, Spârchez Z, Iuga CA, Mocan T, Mihu CM. Novel approaches in search for biomarkers of cholangiocarcinoma. World J Gastroenterol 2022; 28(15): 1508-1525 [DOI: 10.3748/wjg.v28.i15.1508] [Reference Citation Analysis]
37 Ghobadi MZ, Emamzadeh R, Mozhgani SH. Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia/lymphoma; the battle between oncogenes and anti-oncogenes. PLoS One 2021;16:e0247713. [PMID: 33630973 DOI: 10.1371/journal.pone.0247713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lane RE, Korbie D, Hill MM, Trau M. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges.Clin Transl Med. 2018;7:14. [PMID: 29855735 DOI: 10.1186/s40169-018-0192-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 21.3] [Reference Citation Analysis]
39 Liu F, Mao H, Chai S, Mao H. Meta-analysis of the diagnostic value of exosomal miR-21 as a biomarker for the prediction of cancer. J Clin Lab Anal 2021;35:e23956. [PMID: 34492742 DOI: 10.1002/jcla.23956] [Reference Citation Analysis]
40 Reese M, Dhayat SA. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications. J Hematol Oncol 2021;14:141. [PMID: 34496946 DOI: 10.1186/s13045-021-01149-4] [Reference Citation Analysis]
41 Jiang S, Hu C, Liu P, Lu M. Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy. Clin Transl Oncol 2019;21:152-9. [PMID: 30051211 DOI: 10.1007/s12094-018-1918-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
42 Ariston Gabriel AN, Wang F, Jiao Q, Yvette U, Yang X, Al-Ameri SA, Du L, Wang YS, Wang C. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer. Mol Cancer 2020;19:132. [PMID: 32854710 DOI: 10.1186/s12943-020-01245-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
43 Karin-Kujundzic V, Sola IM, Predavec N, Potkonjak A, Somen E, Mioc P, Serman A, Vranic S, Serman L. Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers. Cells 2019;8:E1459. [PMID: 31752198 DOI: 10.3390/cells8111459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
44 He R, Shi J, Xu D, Yang J, Shen Y, Jiang Y, Tao L, Yang M, Fu X, Yang J, Liu D, Huo Y, Shen X, Lu P, Niu N, Sun Y, Xue J, Liu W. SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215693] [Reference Citation Analysis]
45 Li F, Bai M, Xu J, Zhu L, Liu C, Duan R. Long-Term Exercise Alters the Profiles of Circulating Micro-RNAs in the Plasma of Young Women. Front Physiol 2020;11:372. [PMID: 32477155 DOI: 10.3389/fphys.2020.00372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Zhao F, Wei C, Cui MY, Xia QQ, Wang SB, Zhang Y. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis. Aging (Albany NY) 2020;12:9380-404. [PMID: 32420903 DOI: 10.18632/aging.103214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, Pereira SP, Cadamuro M, Rupp C, Loosen SH, Luedde T, Banales JM. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver Int. 2019;39 Suppl 1:108-122. [PMID: 30843325 DOI: 10.1111/liv.14090] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 15.0] [Reference Citation Analysis]
48 Wang C, Wang J, Cui W, Liu Y, Zhou H, Wang Y, Chen X, Chen X, Wang Z. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. Onco Targets Ther 2021;14:1441-51. [PMID: 33664577 DOI: 10.2147/OTT.S296816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tang XH, Guo T, Gao XY, Wu XL, Xing XF, Ji JF, Li ZY. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer 2021;20:99. [PMID: 34330299 DOI: 10.1186/s12943-021-01396-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Zhou J, Guo H, Yang Y, Zhang Y, Liu H. A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients. Medicine (Baltimore). 2019;98:e15335. [PMID: 31008992 DOI: 10.1097/md.0000000000015335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Marzan AL, Stewart SE. Elucidating the Role of Extracellular Vesicles in Pancreatic Cancer. Cancers (Basel) 2021;13:5669. [PMID: 34830825 DOI: 10.3390/cancers13225669] [Reference Citation Analysis]
52 Liu SY, Liao Y, Hosseinifard H, Imani S, Wen QL. Diagnostic Role of Extracellular Vesicles in Cancer: A Comprehensive Systematic Review and Meta-Analysis. Front Cell Dev Biol 2021;9:705791. [PMID: 34722499 DOI: 10.3389/fcell.2021.705791] [Reference Citation Analysis]
53 Gao Z, Jiang W, Zhang S, Li P. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma. Anal Cell Pathol (Amst) 2019;2019:9419072. [PMID: 31583198 DOI: 10.1155/2019/9419072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, Zou Y, Chen S. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. J Exp Clin Cancer Res 2019;38:310. [PMID: 31307515 DOI: 10.1186/s13046-019-1313-x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 23.7] [Reference Citation Analysis]
55 Yee NS, Zhang S, He HZ, Zheng SY. Extracellular Vesicles as Potential Biomarkers for Early Detection and Diagnosis of Pancreatic Cancer. Biomedicines 2020;8:E581. [PMID: 33297544 DOI: 10.3390/biomedicines8120581] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
56 Li S, Wang W. Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis. Front Cell Dev Biol 2021;9:639514. [PMID: 33869189 DOI: 10.3389/fcell.2021.639514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter BS. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas. Adv Biosyst 2020;4:e2000029. [PMID: 32484293 DOI: 10.1002/adbi.202000029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
58 Sharma GG, Okada Y, Von Hoff D, Goel A. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. Semin Cancer Biol 2020:S1044-579X(20)30204-2. [PMID: 33049362 DOI: 10.1016/j.semcancer.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Pu X, Ding G, Wu M, Zhou S, Jia S, Cao L. Elevated expression of exosomal microRNA-21 as a potential biomarker for the early diagnosis of pancreatic cancer using a tethered cationic lipoplex nanoparticle biochip. Oncol Lett 2020;19:2062-70. [PMID: 32194703 DOI: 10.3892/ol.2020.11302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
60 Baassiri A, Nassar F, Mukherji D, Shamseddine A, Nasr R, Temraz S. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer. Int J Mol Sci. 2020;21. [PMID: 32092975 DOI: 10.3390/ijms21041398] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
61 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Yan T, Wang X, Wei G, Li H, Hao L, Liu Y, Yu X, Zhu W, Liu P, Zhu Y, Zhou X. Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation. J Cancer 2021;12:2140-50. [PMID: 33754012 DOI: 10.7150/jca.47817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Abhange K, Makler A, Wen Y, Ramnauth N, Mao W, Asghar W, Wan Y. Small extracellular vesicles in cancer. Bioact Mater 2021;6:3705-43. [PMID: 33898874 DOI: 10.1016/j.bioactmat.2021.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Shang D, Xie C, Hu J, Tan J, Yuan Y, Liu Z, Yang Z. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2. J Cell Mol Med 2020;24:588-604. [PMID: 31724333 DOI: 10.1111/jcmm.14766] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
65 Tesfaye AA, Azmi AS, Philip PA. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma. Am J Pathol 2019;189:58-70. [PMID: 30558723 DOI: 10.1016/j.ajpath.2018.10.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
66 Jiang K, Dong C, Yin Z, Li R, Wang Q, Wang L. The critical role of exosomes in tumor biology. J Cell Biochem 2018. [PMID: 30362158 DOI: 10.1002/jcb.27813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
67 Jin W, Wang L, Cheng S, Lv H. Prognostic value of microRNA-378 in esophageal cancer and its regulatory effect on tumor progression. Exp Ther Med 2021;22:704. [PMID: 34007313 DOI: 10.3892/etm.2021.10136] [Reference Citation Analysis]
68 Salmond N, Williams KC. Isolation and characterization of extracellular vesicles for clinical applications in cancer – time for standardization? Nanoscale Adv 2021;3:1830-52. [DOI: 10.1039/d0na00676a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
69 Zhao Z, Zhao G, Yang S, Zhu S, Zhang S, Li P. The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer. Cancer Cell Int 2021;21:364. [PMID: 34243775 DOI: 10.1186/s12935-021-02059-8] [Reference Citation Analysis]
70 Busso-Lopes AF, Carnielli CM, Winck FV, Patroni FMS, Oliveira AK, Granato DC, E Costa RAP, Domingues RR, Pauletti BA, Riaño-Pachón DM, Aricetti J, Caldana C, Graner E, Coletta RD, Dryden K, Fox JW, Paes Leme AF. A Reductionist Approach Using Primary and Metastatic Cell-Derived Extracellular Vesicles Reveals Hub Proteins Associated with Oral Cancer Prognosis. Mol Cell Proteomics 2021;20:100118. [PMID: 34186243 DOI: 10.1016/j.mcpro.2021.100118] [Reference Citation Analysis]
71 Kawamura S, Iinuma H, Wada K, Takahashi K, Minezaki S, Kainuma M, Shibuya M, Miura F, Sano K. Exosome‐encapsulated microRNA‐4525, microRNA‐451a and microRNA‐21 in portal vein blood is a high‐sensitive liquid biomarker for the selection of high‐risk pancreatic ductal adenocarcinoma patients. J Hepatobiliary Pancreat Sci 2019;26:63-72. [DOI: 10.1002/jhbp.601] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
72 Chu NJ, Anders RA, Fertig EJ, Cao M, Hopkins AC, Keenan BP, Popovic A, Armstrong TD, Jaffee EM, Zimmerman JW. Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development. Cancer Prev Res (Phila) 2020;13:569-82. [PMID: 32409593 DOI: 10.1158/1940-6207.CAPR-20-0053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Flammang I, Reese M, Yang Z, Eble JA, Dhayat SA. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2020;12:E1693. [PMID: 32630552 DOI: 10.3390/cancers12061693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
74 Testa A, Venturelli E, Brizzi MF. Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. Cancers (Basel) 2021;13:2792. [PMID: 34205183 DOI: 10.3390/cancers13112792] [Reference Citation Analysis]
75 Zhu Y, Zhang H, Chen N, Hao J, Jin H, Ma X. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99:e18581. [PMID: 32011436 DOI: 10.1097/md.0000000000018581] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
76 Zhao X, Ren Y, Lu Z. Potential diagnostic and therapeutic roles of exosomes in pancreatic cancer. Biochim Biophys Acta Rev Cancer 2020;1874:188414. [PMID: 32866530 DOI: 10.1016/j.bbcan.2020.188414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Wang L, Wu J, Ye N, Li F, Zhan H, Chen S, Xu J. Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer. Front Oncol 2021;11:739111. [PMID: 34589435 DOI: 10.3389/fonc.2021.739111] [Reference Citation Analysis]
78 Tominaga H, Matsuzaki J, Oikawa C, Toyoshima K, Manabe H, Ozawa E, Shimamura A, Yokoyama R, Serizawa Y, Ochiya T, Saito Y. Challenges for Better Diagnosis and Management of Pancreatic and Biliary Tract Cancers Focusing on Blood Biomarkers: A Systematic Review. Cancers (Basel) 2021;13:4220. [PMID: 34439378 DOI: 10.3390/cancers13164220] [Reference Citation Analysis]
79 Zhao B, Li J, Zhang X, Dai Y, Yang N, Bao Z, Chen Y, Wu X. Exosomal miRNA-181a-5p from the cells of the hair follicle dermal papilla promotes the hair follicle growth and development via the Wnt/β-catenin signaling pathway. Int J Biol Macromol 2022;207:110-20. [PMID: 35248611 DOI: 10.1016/j.ijbiomac.2022.02.177] [Reference Citation Analysis]
80 Rodrigues PM, Vogel A, Arrese M, Balderramo DC, Valle JW, Banales JM. Next-Generation Biomarkers for Cholangiocarcinoma. Cancers (Basel) 2021;13:3222. [PMID: 34203269 DOI: 10.3390/cancers13133222] [Reference Citation Analysis]
81 Han S, Underwood P, Hughes SJ. From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer. Cytokine Growth Factor Rev 2020;51:61-8. [PMID: 32005635 DOI: 10.1016/j.cytogfr.2020.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
82 Fiorini E, Veghini L, Corbo V. Modeling Cell Communication in Cancer With Organoids: Making the Complex Simple. Front Cell Dev Biol. 2020;8:166. [PMID: 32258040 DOI: 10.3389/fcell.2020.00166] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
83 Qian L, Yu S, Chen Z, Meng Z, Huang S, Wang P. Functions and clinical implications of exosomes in pancreatic cancer. Biochim Biophys Acta Rev Cancer 2019;1871:75-84. [PMID: 30419313 DOI: 10.1016/j.bbcan.2018.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
84 Zhu L, Zhao L, Wang Q, Zhong S, Guo X, Zhu Y, Bao J, Xu K, Liu S. Circulating exosomal miRNAs and cancer early diagnosis. Clin Transl Oncol 2021. [PMID: 34524618 DOI: 10.1007/s12094-021-02706-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Al Bitar S, Ballouz T, Doughan S, Gali-Muhtasib H, Rizk N. Potential role of micro ribonucleic acids in screening for anal cancer in human papilloma virus and human immunodeficiency virus related malignancies. World J Gastrointest Pathophysiol 2021; 12(4): 59-83 [PMID: 34354849 DOI: 10.4291/wjgp.v12.i4.59] [Reference Citation Analysis]
86 Liu DSK, Mato Prado M, Giovannetti E, Jiao LR, Krell J, Frampton AE. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma? Expert Rev Mol Diagn 2019;19:553-8. [PMID: 31159604 DOI: 10.1080/14737159.2019.1622414] [Reference Citation Analysis]
87 Gablo NA, Prochazka V, Kala Z, Slaby O, Kiss I. Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. Curr Genomics 2019;20:569-80. [PMID: 32581645 DOI: 10.2174/1389202921666191217095017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 Nakamura S, Sadakari Y, Ohtsuka T, Okayama T, Nakashima Y, Gotoh Y, Saeki K, Mori Y, Nakata K, Miyasaka Y, Onishi H, Oda Y, Goggins M, Nakamura M. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2019;26:2104-2111. [PMID: 30820789 DOI: 10.1245/s10434-019-07269-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
89 Perales S, Torres C, Jimenez-Luna C, Prados J, Martinez-Galan J, Sanchez-Manas JM, Caba O. Liquid biopsy approach to pancreatic cancer. World J Gastrointest Oncol 2021; 13(10): 1263-1287 [PMID: 34721766 DOI: 10.4251/wjgo.v13.i10.1263] [Reference Citation Analysis]
90 Petersen EV, Chudakova DA, Skorova EY, Anikin V, Reshetov IV, Mynbaev OA. The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors. Front Oncol 2020;10:575569. [PMID: 33425730 DOI: 10.3389/fonc.2020.575569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
91 Sheveleva ON, Domaratskaya EI, Payushina OV. Extracellular Vesicles and Prospects of Their Use for Tissue Regeneration. Biochem Moscow Suppl Ser A 2019;13:1-11. [DOI: 10.1134/s1990747818040104] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Peng C, Wang J, Gao W, Huang L, Liu Y, Li X, Li Z, Yu X. Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer. Int J Med Sci 2021;18:660-71. [PMID: 33437201 DOI: 10.7150/ijms.52706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Špilak A, Brachner A, Kegler U, Neuhaus W, Noehammer C. Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles. Adv Drug Deliv Rev 2021;175:113819. [PMID: 34087328 DOI: 10.1016/j.addr.2021.05.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
94 Heydari R, Abdollahpour-Alitappeh M, Shekari F, Meyfour A. Emerging Role of Extracellular Vesicles in Biomarking the Gastrointestinal Diseases. Expert Rev Mol Diagn 2021;:1-24. [PMID: 34308738 DOI: 10.1080/14737159.2021.1954909] [Reference Citation Analysis]
95 Nannan L, Oudart JB, Monboisse JC, Ramont L, Brassart-Pasco S, Brassart B. Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer. Front Oncol 2020;10:1456. [PMID: 32974169 DOI: 10.3389/fonc.2020.01456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
96 Uddin MH, Al-Hallak MN, Philip PA, Mohammad RM, Viola N, Wagner KU, Azmi AS. Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Cancers (Basel) 2021;13:2777. [PMID: 34204940 DOI: 10.3390/cancers13112777] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Uzuner E, Ulu GT, Gürler SB, Baran Y. The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment. Methods Mol Biol 2022;2257:375-422. [PMID: 34432288 DOI: 10.1007/978-1-0716-1170-8_18] [Reference Citation Analysis]
98 Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochim Biophys Acta Rev Cancer 2020;1873:188318. [PMID: 31676330 DOI: 10.1016/j.bbcan.2019.188318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
99 Wang YF, Lian XL, Zhong JY, Su SX, Xu YF, Xie XF, Wang ZP, Li W, Zhang L, Che D, Yu L, Huang P, Jia HL, Gu XQ. Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm. IUBMB Life 2019;71:891-900. [PMID: 30724444 DOI: 10.1002/iub.2015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Hilton SH, White IM. Advances in the analysis of single extracellular vesicles: A critical review. Sensors and Actuators Reports 2021;3:100052. [DOI: 10.1016/j.snr.2021.100052] [Reference Citation Analysis]
101 Ohayon L, Zhang X, Dutta P. The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease. Pharmacol Res 2021;170:105692. [PMID: 34182130 DOI: 10.1016/j.phrs.2021.105692] [Reference Citation Analysis]
102 Konishi H, Sato H, Takahashi K, Fujiya M. Tumor-Progressive Mechanisms Mediating miRNA-Protein Interaction. Int J Mol Sci 2021;22:12303. [PMID: 34830186 DOI: 10.3390/ijms222212303] [Reference Citation Analysis]
103 Kuratomi N, Takano S, Fukasawa M, Maekawa S, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Kawakami S, Hayakawa H, Takada H, Nakakuki N, Kato R, Yamaguchi T, Nakayama Y, Kawaida H, Kono H, Inoue T, Kondo T, Ichikawa D, Enomoto N. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing. Int J Mol Sci 2021;22:3221. [PMID: 33809988 DOI: 10.3390/ijms22063221] [Reference Citation Analysis]